trastuzumab deruxtecan
daiichi sankyo,astrazeneca
[]
 at plenary redefining her-2 positivity #brcm #tdxd 
Translational Medical Oncologist (Biomarkers, Toxicities, Health Outcomes, Clinico-Genomic Big Data) @OncoAlert. Motto: "Let's make a difference". Views mine.